We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 526 results
  1. Combinatorial strategies for production improvement of anti-tuberculosis antibiotics ilamycins E1/E2 from deep sea-derived Streptomyces atratus SCSIO ZH16 ΔilaR

    Ilamycins E 1 /E 2 are novel cyclic heptapeptides from Streptomyces atratus SCSIO ZH16, which have the MIC value of 9.8 nM against Mycobacterium...

    Yunfei Zhu, Gaofan Zheng, ... Faliang An in Bioresources and Bioprocessing
    Article Open access 22 October 2022
  2. Nanotechnology in TB Diagnosis

    Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (Mtb), is still a significant worldwide health issue, and it is the second...
    Jayvadan Patel, Anita Patel, Nisarg Patel in Infectious Diseases Drug Delivery Systems
    Chapter 2023
  3. Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays

    Multidrug-resistant tuberculosis (MDR-TB) continues to spread worldwide and remains one of the leading causes of death among infectious diseases. The...

    Qianqian Zhang, Jianting Han, ... Huanxiang Liu in Journal of Computer-Aided Molecular Design
    Article 29 August 2023
  4. Recent Developments in Medicinal and In Silico Applications of Imidazopyridine Derivatives: Special Emphasis on Malaria, Trypanosomiasis, and Tuberculosis

    People from low-income countries are increasingly affected by neglected communicable diseases, and the health care system frequently overlooks their...

    Suraj N. Mali, Anima Pandey in Chemistry Africa
    Article 10 September 2022
  5. Plant Secondary Metabolites as a Source of New Drugs

    An increasing number of new pathogens, the emergence of multidrug drug-resistant (MDR) and extremely drug-resistant (XDR) bacterial and fungal...
    Ravindra H. Patil, Mohini P. Patil, Vijay L. Maheshwari in Apocynaceae Plants
    Chapter 2023
  6. Nanotechnology-Based Vaccination for TB

    With a projected global target to end the tuberculosis epidemic by the year 2030, United Nations termed this as an important Sustainable Development...
    Anwesha Barik, Sanjay Dey in Infectious Diseases Drug Delivery Systems
    Chapter 2023
  7. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach

    Mycobacterium tuberculosis (Mtb) is a respiratory pathogen that causes tuberculosis (TB). There are a large number of proteins that are involved in...

    R. Logesh, V. Lavanya, ... Neesar Ahmed in Applied Biochemistry and Biotechnology
    Article 24 November 2021
  8. Multiple 3D- and 2D-quantitative structure–activity relationship models (QSAR), theoretical study and molecular modeling to identify structural requirements of imidazopyridine analogues as anti-infective agents against tuberculosis

    Tuberculosis (TB), an infectious remains a global health burden till date. Considering immense importance of theoretical tools in computer aided-drug...

    Suraj N. Mali, Anima Pandey, ... Chin-Hung Lai in Structural Chemistry
    Article 24 January 2022
  9. Synthesis, Antitubercular Evaluation, Molecular Docking Study, and Teratogenicity Studies of Novel Triazolo Quinazoline Hybrids

    Abstract

    A novel series of triazole-quinazoline hybrid molecules was synthesized and characterized by spectral analyses. The H37 R V strain was used...

    N. Raghavendra Babu, B. M. Sahoo, ... N. Malothu in Russian Journal of General Chemistry
    Article 01 October 2023
  10. Antimicrobial Potentials of Zinc and Iron Oxide Nanoparticles

    One of the most important issues in global healthcare is the development of antimicrobial or antibiotic resistance (AMR or ABR) in microorganisms....
    Mansee Thakur, Smital Poojary, ... Vinay Kumar in Nano-Strategies for Addressing Antimicrobial Resistance
    Chapter 2022
  11. Comparison of Multi-metallic Nanoparticles-Alternative Antibacterial Agent: Understanding the Role of Their Antibacterial Properties

    The rise of antibiotic-resistant infectious diseases caused by various bacterial pathogens has emerged as a major global health concern. As a result,...

    Parvathalu Kalakonda, Pritam Mandal, ... Bala Bhaskar Podila in Journal of Inorganic and Organometallic Polymers and Materials
    Article 25 January 2024
  12. Secondary Metabolites: Treasure Trove for Future Medicine

    Secondary metabolites are organic substances produced by various living organisms (e.g., bacteria, fungi, plants, animals) that do not have any...
    Rangan Mitra, Suparna Ghosh, ... Avik Acharya Chowdhury in Plant Specialized Metabolites
    Living reference work entry 2023
  13. Microbicidal Nanoparticles

    Nanomaterials exhibit tremendous exciting properties and transform every aspect of science and technology. Microbiology has also not remained...
    Nishant Srivastava, Shailendra K. Saxena in Synthesis and Applications of Nanoparticles
    Chapter 2022
  14. Extensively Drug-resistant Tuberculosis (XDR-TB)-inhibitors to Overcome the Scourge of Drug-resistant Tuberculosis: a Perspective

    Abstract

    TB is the 9th leading cause of death worldwide above HIV/AIDS. Tuberculosis (TB) management remains challenging due to the emergence of...

    Harun Patel, Iqrar Ahmad, ... Sanjay Surana in Reviews and Advances in Chemistry
    Article 01 July 2020
  15. Mucosal Targeting Strategies for Antiviral Drug Delivery

    Antiviral drug efficacy and bioavailability are critical factors in the treatment of viral infections. The existence of new viral infections...
    Tayo Alex Adekiya, Mumuni Sumaila, ... Yahya E. Choonara in Viral Drug Delivery Systems
    Chapter 2023
  16. Polymer-Based Nanotechnology to Combat the Emergence of Drug Resistance in Bacteria

    Multidrug-resistant bacteria are posing a great threat to human beings. To address that challenge, polymer-based nanomaterials have come into the...
    Yuanfeng Li, Tieli Zhou, ... Yong Liu in Recent Progress in Nanobiotechnology
    Chapter 2024
  17. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach

    Cases of drug-resistant tuberculosis (TB) have increased worldwide in the last few years, and it is a major threat to global TB control strategies...

    Sanket Rathod, Pooja Chavan, ... Firoj Tamboli in Journal of Molecular Modeling
    Article 27 March 2023
  18. Marine Pharmacology: Potentialities in the Treatment of Infectious Diseases, Osteoporosis and Alzheimer's Disease

    Several molecules isolated from various marine organisms (microorganisms, algae, fungi, invertebrates, and vertebrates) are currently under study...
    M.-L. Bourguet-Kondracki, J.-M. Kornprobst in Marine Biotechnology II
    Chapter
  19. Exploring Microbial Nanotoxicity Against Drug Resistance in Bacteria

    The growing threat of antimicrobial resistance on human health urgently calls for the need to look for novel solutions to mitigate the grave effect...
    Rajeshwari Sinha, Ayesha Sadaf, Sunil K. Khare in Nanotoxicology and Nanoecotoxicology Vol. 1
    Chapter 2021
  20. Zinc Oxide Nanoparticles in Biomedical Applications: Advances in Synthesis, Antimicrobial Properties, and Toxicity Considerations

    Zinc oxide (ZnO) nanoparticles are promising nanotherapeutics used in several biomedical applications. Some of the unique features of ZnO...
    Chapter 2024
Did you find what you were looking for? Share feedback.